Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2015 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2015 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression

  • Authors:
    • Xiling Du
    • Haipeng Wang
    • Fuhui Xu
    • Yongyi Huang
    • Zhixue Liu
    • Te Liu
  • View Affiliations / Copyright

    Affiliations: School of Life Science and Technology, Tongji University, Shanghai 200092, P.R. China
    Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 953-959
    |
    Published online on: March 13, 2015
       https://doi.org/10.3892/mmr.2015.3482
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Enterovirus 71 (EV71) is a pathogenic microorganism that causes hand, foot and mouth disease. However, the epigenetic mechanisms behind how EV71 regulates host cell proliferation and apoptosis are unclear. In the present study, the ability of EV71 to induce apoptosis was analyzed in the SH‑SY5Y human neuroblastoma cell line and the effect of this virus on the mRNA expression levels of various apoptotic markers, miRNA let‑7b and cyclin D1 (CCND1), was also investigated. The results demonstrated that EV71 induced SH‑SY5Y cell apoptosis. An MTT assay revealed a significant inhibitory effect of EV71 on cell proliferation between 12‑72 h post injection, compared with the control group. Furthermore, quantitative polymerase chain reaction and western blot analyses demonstrated that expression level of the apoptosis inhibitor Bcl‑2 was markedly reduced, but the expression levels of the apoptosis‑promoting factors Bax, caspase‑7, caspase‑3 and active caspase‑3 were markedly higher in the SH‑SY5Y cells 12‑48 h after EV71 infection, compared with the non‑infected cells. In addition, flow cytometric assays revealed that EV71 arrested the cell cycle of host SH‑SY5Y cells. Northern blot analysis revealed a marked miRNA let‑7b hybridization signal in the EV71 virus‑infected group compared with the non‑infected group. Furthermore, western blotting confirmed that the CCND1 protein expression levels were significantly reduced in EV71‑infected SH‑SY5Y cells. EV71‑inhibited SH‑SY5Y proliferation was abrogated using let‑7b specific 2'‑O‑Methyl‑RNA, which inhibited endogenous miRNA let‑7b expression. Thus, EV71 regulated the host SH‑SY5Y cell cycle and cell proliferation via stimulating endo­genous miRNA let‑7b and directly targeting CCND1, therefore EV71 is a potential candidate for antiviral therapy.

Introduction

More than 500,000 hand, foot and mouth disease (HFMD) cases caused by human enterovirus 71 (EV71) are reported in the People’s Republic of China annually, including 176 fatal cases since March 2008 (1). One study has shown that EV71 and Coxsackie virus A16 (CVA16) are the two predominant causative agents of HFMD, accounting for >70% of recent outbreaks (2). EV71 infection is more frequently associated with serious neurological diseases, such as aseptic meningitis, encephalitis and acute flaccid paralysis, while CVA16-associated HFMD has a milder outcome (1). Although the pathogens that cause HFMD have been confirmed, the association between host cells and the HFMD viruses, and the mechanism by which the HFMD virus induces host cell apoptosis remains unclear. An increasing number of studies have revealed that numerous viral infections, including hepatitis B virus, hepatitis C virus, human immunodeficiency virus and sarcoma-associated herpes virus, among others, are closely associated with the regulation of miRNAs (miRNAs) (3–6). miRNAs are a class of naturally occurring single-stranded short 21–23 nt non-coding RNAs (7,8) that exist in a wide range of eukaryotic organisms (7–12). Each mammalian miRNA prevents the translation of a number of downstream target mRNAs and ultimately results in the inhibition of target gene expression (13,14). Therefore, a shift away from the manipulation of crucial target genes towards miRNA interference techniques may improve the effectiveness of current gene-based diagnostic and therapeutic strategies (9). Although the majority of miRNA studies focus on the growth and differentiation of stem cells (15–17), tumorigenesis (18,19) and other pathological processes (13,14), few studies have focused on the role of miRNAs in the interaction between EV71 and human neurons. Thus far, certain studies have reported that miRNAs are involved in the host response to EV71 infection. Cui et al (1) used a deep sequencing approach to determine that 64 miRNAs in host cells exhibited >2-fold expression level changes in response to EV71 infection. Wen et al (20) found that miRNA-23b in host cells inhibited EV71 replication through downregulation of the EV71 viral capsid protein (VPl). Zheng et al (21) showed that miRNA-296-5p suppressed EV71 replication in host cells by inhibiting two potential targets (2,115-2,135 nt and 2,896-2,920 nt) located in the EV71 genome. Furthermore, Li et al (22) demonstrated that the members of the miRNA-548 family, including miR-548b-5p, miR-548c-5p, miR-548i, miR-548j and miR-548n, downregulate the host antiviral response during EV71 or vesicular stomatitis virus infection via direct targeting of interferon-λ1. In addition, Cui et al (2) compared host serum miRNA levels in patients with HFMD caused by EV71 and CA16 as well as in healthy individuals. In the sera of patients with the enteroviral infections, 102 miRNAs were upregulated and 26 miRNAs were downregulated. Therefore, altered circulating miRNA profiles have been observed in patients with microbial infections. These results enhance the understanding of miRNA involvement resulting from EV71 infection in HFMD and offer insight into potential prevention and treatment approaches.

Let-7 is a well-known miRNA known to regulate cell cycle and development, that is underexpressed in various types of cancer (23). Restoration of normal let-7 expression levels has been demonstrated to inhibit cancer growth by targeting various oncogenes and inhibiting the key regulators of several mitogenic signaling pathways (23–26). Yu et al (26) found that let-7 suppressed self-renewal and tumorigenicity in breast cancer cells by reducing H-RAS and high-mobility group AT-hook (HMGA) 2 expression levels. Furthermore, Schultz et al (24) reported that let-7b, a member of the let-7 miRNA family, interfered with the proliferation and growth of primary malignant melanoma cells by targeting and suppressing important cell cycle molecules, such as cyclin D (CCND1). In addition, Dangi-Garimella et al (25) revealed that elevated let-7 expression levels inhibited HMGA2 expression and suppressed metastasis in breast cancer cells. In view of this evidence, whether EV71 stimulates endogenous miRNA let-7 expression to inhibit growth and proliferation, and induce apoptosis in host cells was investigated in the present study.

Materials and methods

Cell culture and viral infection

The SH-SY5Y human neuroblastoma cell line, which was purchased from the Cell Resources Center of Shanghai Institute of Life Science, Chinese Academy of Sciences (Shanghai, China) was grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/ml), streptomycin (100 U/ml) and 2 mM L-glutamine (all purchased from Hyclone, Logan, USA). The SH-SY5Y cells were at 37°C in a humidified atmosphere of air containing 5% CO2. The prototype EV71 was donated by Dr Weihao Li (Handan Municipal Center for Disease Prevention and Control, Hubei, China). The SH-SY5Y cells were infected with EV71 virus as previously described (1,27). Briefly, SH-SY5Y cells were grown to 80% confluence prior to infection. For virus absorption, the cells were infected for 60 min with EV71 at a multiplicity of infection (MOI) of 1, 50% tissue culture infectious doses, in serum-free medium. Following infection, the cells were washed with phosphate-buffered saline (PBS) and maintained at 37°C in DMEM medium with 2% FBS.

Reverse transcription (RT) and quantitative polymerase chain reaction (qPCR) analysis

Total RNA was isolated from each cell type using TRIzol® Reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s instructions. The RNA samples were subsequently treated with DNase I (Sigma-Aldrich, St. Louis, MO, USA), quantified and reverse-transcribed to cDNA using the ReverTra Ace-α First Strand cDNA Synthesis kit (Toyobo Co., Ltd., Osaka, Japan). The qPCR was conducted using a RealPlex4 real-time PCR detection system (Eppendorf, Hamburg, Germany) with SYBR Green Realtime PCR Master mix (Toyobo Co., Ltd.). The qPCR amplification was performed over 40 cycles of denaturation at 95°C for 15 sec and annealing at 58°C for 45 sec, and target cDNA was measured using the relative quantification method. The comparative threshold cycle (Ct) calculation was used to determine the relative gene expression levels, normalized to 18S rRNA. For each sample, the Ct values were normalized using the formula: ΔCt = Ct_genes - Ct_18S RNA. The relative expression levels were calculated using the formula: ΔΔCt = ΔCt_all_groups - ΔCt_blank control_group. The values used to plot relative gene expression levels were calculated using 2−ΔΔCt. The primers used for the cDNA amplification were as previously described (15).

Transmission electron microscopy (TEM) analysis

TEM analysis was conducted as previously described (28). Briefly, each group of cells was fixed in 1% glutaraldehyde 1 h prior to post-fixing in 1% osmium tetroxide for 1 h, then the cells were dehydrated in an acetone dilution series and embedded in resin 12 (Ted Pella, Inc., Redding, CA, USA). Transverse sections (900 nm) were stained with toluidine blue (Sigma-Aldrich, St. Louis, MO, USA) and examined using a Nikon Eclipse 80i microscope (Nikon Instruments, Inc., Melville, NY, USA). Ultra-thin sections (70 nm) were stained with 1% uranyl acetate and 1% lead citrate, and examined using a JEM-1230 (JEOL, Tokyo, Japan) transmission electron microscope.

Terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL) assay

TUNEL assay was performed as previously described (27,29). Briefly, each group of cells treated as indicated was fixed with 4% paraformaldehyde, rinsed with PBS, then permeabilized with 0.1% Triton X-100 for fluorescein isothiocyanate (FITC)-end-labeling the fragmented DNA of apoptotic SH-SY5Y cells using a TUNEL cell apoptosis detection kit (Beyotime Institute of Biotechnology, Shanghai, China). The FITC-labeled TUNEL-positive cells were imaged under a fluorescent microscope (DMI3000; Leica, Allendale, NJ, USA) using 488 nm excitation and 530 nm emission.

Northern blotting

Northern blotting was conducted as previously described (17). For all cell treatment groups, total RNA was isolated from each cell type using TRIzol reagent (Invitrogen Life Technologies), according to the manufacturer’s instructions. The RNA samples were subsequently treated with DNase I (Sigma-Aldrich), and 20 μg total RNA was analyzed on a 7.5 M urea, 12% polyacrylamide denaturing gel, then transferred to a Hybond N+ nylon membrane (Amersham, Freiburg, Germany). The membranes were cross-linked using ultraviolet light for 30 s at 1,200 mJ/cm2 and hybridized to the let-7b antisense starfire probe (GenScript, Piscataway, NJ, USA), for the detection of 21 nt let-7b fragments, according to the manufacturer’s instructions. Following washing, the membranes were exposed to Kodak XAR-5 film for 20–40 h (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). A human U6 snRNA probe, 5′-G CAGGGGCCATGCTAATCTTCTCTGTATCG-3′, served as a positive control. The exposure time was 15–30 min.

Western blotting

Total proteins extracts of each cell treatment group were resolved by 12% SDS-PAGE and transferred onto polyvinylidene difluoride (Millipore, Billerica, MA, USA) membranes. The membranes were blocked with Tris-buffered saline containing 0.3% Tween-20 (TBST) and 5% normal goat serum at 37°C for 60 min. Subsequent to blocking, the membranes were washed four times for 15 min with TBST at room temperature and then incubated with the following primary polyclonal antibodies: Rabbit anti-human EV71 (1:1,000; Millipore), rabbit anti-human CDK4, rabbit anti-human caspase-3, rabbit anti-human active caspase-3, rabbit anti-human Bcl-2, rabbit anti-human BAX and rabbit anti-GAPDH (1:1,000; all Cell Signaling Technology, Inc., Danvers, MA, USA). The membranes were washed four times for 15 min with TBST at room temperature. Following washing, the membranes were incubated at room temperature with peroxidase-linked goat anti-rabbit IgG secondary antibody (1:1,000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) for 1 h. Protein bands were visualized by autoradiography, using an enhanced chemiluminescence kit (Pierce Biotechnology, Inc., Rockford, IL, USA).

Flow cytometric (FCM) analysis of the cell cycle by propidium iodide (PI) staining

A total of 3×105 cells per well were seeded in 6-well plates and cultured until 85% confluent. Each group of cells was washed with PBS three times, then collected by centrifugation (Allegra X-22R; Beckman Coulter, Miami, FL, USA) at 1,000 × g for 5 min. The cell pellets were subsequently resuspended in 1 ml PBS, fixed in 70% ice-cold ethanol and stored in a freezer for >48 h at −20°C. Prior to flow cytometric analysis, the fixed cells were centrifuged, washed twice with PBS and resuspended in PI staining solution (Sigma-Aldrich Chemie GmbH) containing 50 μl/ml PI and 250 μg/ml RNase A (Sigma-Aldrich Chemie GmbH). The cell suspension was incubated for 30 min at 4°C in the dark, and analyzed by FACS (FCM-500; Beckman Coulter). A total of 20,000 events were recorded for analysis using CellQuest™ software (BD Biosciences, Franklin Lakes, NJ, USA).

MTT assay of cell proliferation

Each group of cells was seeded at 2×103 cells per well in 96-well plates and cultured in DMEM supplemented with 10% FBS at 37°C with 5% CO2, until 85% confluent. MTT reagent (5 mg/ml; Sigma-Aldrich Chemie GmbH) was added to the cell medium at different time points and incubated at 37°C for an additional 4 h. The reaction was terminated by adding 150 μl dimethylsulfoxide (Sigma-Aldrich Chemie GmbH) per well and the cells were lysed for 15 min, with the plates gently agitated every 5 min. The absorbance values were determined using an enzyme-linked immunosor-bent assay reader (Model 680; Bio-Rad, Hercules, CA, USA) at 490 nm.

2′-O-Me RNA transfected

The 2′-O-Me RNA oligonucleotide, targeting silenced miRNA let-7b, was synthesized by Shanghai GenePharma Co.,Ltd., (Shanghai, China). The SH-SY5Y cells were transfected with 20 μM 2′-O-Me using Lipofectamine 2000 (Invitrogen Life Technologies), according to the manufacturer’s instructions.

Statistical analysis

Each experiment was performed at least three times. The data are presented as the means ± standard error of the mean, where applicable, and the differences were evaluated using Student’s t-test with SPSS 18.0 statistical software (SPSS, Inc., Chicago, IL, USA). A P<0.05 was considered to indicate a statistically significant difference.

Results

EV71 induces SH-SY5Y human neuroblastoma cell apoptosis

To determine whether EV71 suppressed SH-SY5Y cell proliferation, an MTT assay was performed at 0, 12, 24, 48 and 72 h after infection (Fig. 1). At the 12–72 h time points, the wild-type (WT) and PBS groups were significantly less susceptible to the proliferation inhibitory effect of EV71 than the EV71 group (Table I). Furthermore, EV71 suppressed SH-SY5Y proliferation in a time-dependent manner, but no significant differences were identified between the WT and the PBS group at any time point. In addition, cell morphology confirmed that the original SH-SY5Y cells were healthy, and there was no indication of apoptosis or necrosis prior to EV71 infection (Fig. 1). However, 48 h after EV71 infection, SH-SY5Y cells exhibited features typical of apoptosis: The cells were round and no longer adherent, and fewer cell pseudopods were observed. In addition, TEM analysis revealed increased numbers of intracellular vacuoles in SH-SY5Y cells 48 h post EV71 infection, compared with the control cells at this time point. In addition, typical EV71 virus particles within or surrounding the SH-SY5Y cells were identified (Fig. 1). Furthermore, TUNEL assay revealed a strong FITC hybridization signal in the EV71 infection group at 48 h, that was not evident in the non-infected cells (Fig. 1). These results demonstrate that the EV71 virus induced SH-SY5Y apoptosis.

Figure 1

Enterovirus (EV)71 inhibited SH-SY5Y human neuroblastoma cell proliferation. (A) An MTT proliferation assay was used to determine the ability of EV71 to suppress SH-SY5Y cell proliferation at 0, 12, 24, 48 and 72 h after infection. Between 12 and 72 h, EV71-infected cells exhibited significant proliferation inhibition compared with control cells (**P<0.01 and #P>0.05 vs. wild-type (WT) group; n=3). (B) Cell morphological analysis confirmed that 48 h after EV71 virus infection, SH-SY5Y cells exhibited signs typical of apoptosis (round, no longer adherent, fewer cell pseudopods). Magnification, ×200. (C) Transmission electron scanning analysis revealed EV71 virus particles within or surrounding SH-SY5Y cells (scale bar=1 μm; magnification, ×10,000). (D) Terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling assay showed a strong fluorescein isothiocyanate hybridization signal in the EV71-infected group at 48 h, but not in non-infected SH-SY5Y cells (0 h; magnification, ×200).

Table I

Analysis of SH-SY5Y cell proliferation inhibition rate following EV71 infection, by MTT assay.

Table I

Analysis of SH-SY5Y cell proliferation inhibition rate following EV71 infection, by MTT assay.

Time (h)EV71 (MOI=1; %)PBS (%)WT (%)
01.67±1.682.32±0.601.15±1.54
1229.57±5.75**3.90±1.545.65±2.64
2447.36±2.52**3.88±2.731.32±1.26
4848.91±12.54**5.22±2.907.27±2.98
7261.68±12.19**5.37±2.693.97±0.96

** P<0.05, vs. WT group; n=3. EV71, enterovirus 71; PBS, phosphate-buffered saline; WT, wild-type; MOI, multiplicity of infection.

To determine how EV71 virus induced apoptosis in the SH-SY5Y cells, qPCR and western blotting were used to measure the expression levels of apoptosis-related factors. qPCR revealed that the mRNA expression levels of the apoptosis inhibitor Bcl-2 were markedly lower in the SH-SY5Y cells 12–48 h post EV71 infection, compared with the non-infected cells (0 h). By contrast, the mRNA expression levels of the apoptosis-promoting factors Bax, caspase-7 and caspase-3 were markedly higher in SH-SY5Y cells 12–48 h post EV71 infection, compared with non-infected cells (0 h). In addition, western blot analysis found that the Bcl-2 protein expression levels were significantly reduced in SH-SY5Y cells 12–48 h post EV71 infection compared with non-infected cells (0 h). Furthermore, the Bax, caspase-3 and active caspase-3 protein expression levels were significantly elevated in SH-SY5Y cells 12–48 h post EV71 infection compared with non-infected cells (Fig. 2). These data indicate that EV71 virus stimulated the expression of apoptosis-related proteins to induce apoptosis.

Figure 2

Enterovirus (EV)71-induced apoptosis-related protein expression. (A) The expression levels of EV71 core RNA in SH-SY5Y human neuroblastoma cells determined by reverse transcription polymerase chain reaction (RT-PCR), normalized to cellular 18S rRNA (**P<0.01 vs. 0 h; n=3). (B) RT-PCR revealed that mRNA expression levels of the apoptosis inhibitor Bcl-2 were markedly lower in the SH-SY5Y cells following EV71 infection between 12 and 48 h compared with non-infected cells (0 h). By contrast, mRNA expression levels of the apoptosis-promoting factors Bax, caspase-7 and caspase-3 were markedly higher in SH-SY5Y cells 12 to 48 h after EV71 infection compared with non-infected cells (0 h; **P<0.01, *P<0.05 and #P>0.05 vs. 0 h; n=3). (C) Western blotting confirmed that Bcl-2 protein expression levels were significantly reduced in SH-SY5Y cells 12 to 48 h after EV71 infection compared with non-infected cells (0 h). Furthermore, Bax, caspase-3 and active caspase-3 protein expression levels were significantly elevated in SH-SY5Y cells 12 to 48 h after EV71 infection compared with non-infected cells. GAPDH served as a loading control (**P<0.01, *P<0.05 and #P>0.05 vs. 0 h; n=3).

EV71 stimulates endogenous miRNA let-7b and inhibits CCND1 expression

FCM was used to determine whether EV71 influenced the SH-SY5Y cell cycle. Subsequent to co-culture with the EV71 virus, the SH-SY5Y cells underwent significant cell cycle arrest. Compared with non-infected cells, a greater number of SH-SY5Y cells were arrested in the G2/M phase and the percentage of cells in the S phase was significantly lower (Fig. 3A). These results suggest that EV71 significantly affected cell cycle regulation in the SH-SY5Y cells. Northern and western blotting were used to determine whether the expression levels of endogenous miRNA let-7b were different between EV71 virus-infected SH-SY5Y cells and control cells. The northern blot analysis revealed a marked let-7b hybridization signal in the EV71-infected group, compared with non-infected SH-SY5Y cells (Fig. 3B). Furthermore, western blotting confirmed that CCND1 protein expression levels were significantly reduced in the EV71-infected SH-SY5Y cells at each time point (0.481±0.192, 0.257±0.123 and 0.119±0.085, respectively), compared with the non-infected cells (0.496±0.178; Fig 3C). These data indicate that the expression levels of endogenous miRNA let-7b were significantly higher and those of CCND1 protein were significantly lower in the SH-SY5Y cells following EV71 infection.

Figure 3

Enterovirus (EV)71 arrested the SH-SY5Y human neuroblastoma cell cycle via regulation of let-7b and cyclin D1 (CCND1) expression levels. (A) Flow cytometry results revealed that compared with non-infected cells, SH-SY5Y cells were arrested in G2/M phase of the cell cycle and the percentage of cells in the S phase was significantly reduced following infection. (B) Northern blot analysis indicated a marked let-7b hybridization signal in the EV71-infected group compared with the non-infected SH-SY5Y cells (0 h). (C) Western blotting confirmed that CCND1 protein expression levels were significantly reduced in EV71-infected SH-SY5Y cells at each time point compared with non-infected cells. GAPDH served as a loading control (**P<0.01, *P<0.05 and #P>0.05. 0 h; n=3).

Inhibiting endogenous miRNA let-7b expression levels with 2′-O-Methyl-RNA maintains SH-SY5Y proliferation

To confirm that EV71 induces host cell SH-SY5Y apoptosis by influencing let-7b, 2′-O-Methyl-RNA was used to inhibit endogenous let-7b expression levels. Northern blot analysis revealed significantly increased let-7b hybridization in the EV71-infected SH-SY5Y cells (mock group). However, a significant reduction in let-7b hybridization signal was observed in the EV71-infected 2′-O-Me group and in the SH-SY5Y cells without viral infection (WT group; Fig. 4A). In addition, western blot analysis confirmed that the protein expression levels of CCND1 were significantly increased in the WT and the 2′-O-Me groups, compared with the mock group (Fig. 4B). However, the protein expression levels of caspase-3 and active caspase-3 were significantly reduced in the WT and 2′-O-Me groups, compared with the mock group (Fig. 4B). In addition, compared with the mock group, the FCM results revealed that the cell cycle of the 2′-O-Me group was modified and the percentage of cells in G2/M phase was markedly reduced (Fig. 4C).

Figure 4

Inhibiting endogenous miRNA let-7b expression with 2′-O-Methyl-RNA maintains SH-SY5Y human neuroblastoma cell proliferation following enterovirus (EV)71 infection. (A) Northern blot analysis revealed a low let-7b hybridization signal in the 2′-O-Methyl-RNA-transfected group compared with the mock-transfected or wild-type (WT) groups. (B) Western blotting confirmed that cyclin D (CCND1) protein expression levels were significantly elevated following EV71 infection in 2′-O-Methyl-RNA-transfected SH-SY5Y cells. However, caspase-3 and active caspase-3 protein expression levels were significantly reduced following EV71 infection in 2′-O-Methyl-RNA-transfected SH-SY5Y cells. GAPDH served as a loading control (**P<0.01, *P<0.05 and #P>0.05 vs. WT; n=3). (C) Flow cytometry results revealed that in 2′-O-Methyl-RNA transfected SH-SY5Y cells, the cell cycle status improved and the percentage of cells in G2/M phase was significantly reduced (*P<0.05 and #P>0.05 vs. mock-transfected group; n=3).

Discussion

Thus far, miRNAs have been demonstrated to be important in the complicated interactions between virus and host in HFMD. The majority of reports indicate that miRNAs inhibit EV71 replication in host cells by downregulating the expression levels of viral core proteins (1,2,17,20–22). However, the present study was the first, to the best of our knowledge, to analyze the role of EV71 in stimulating the endogenous miRNAs of host cells in order to facilitate the induction of host cell apoptosis following infection. Typically, EV71 transfers genetic material into host cells through cell membrane receptors, then utilizes host cell machinery to assist viral processing (1,2), including replication and packaging, prior to producing viral particles (1,2). Simultaneously, host cells gradually undergo necrosis or apoptosis due to cell destruction by EV71. However, how the EV71 virus induces host cell apoptosis following infection remains unclear. Several studies have reported that host cellular miRNAs inhibit EV71 infection and replication, and that virus mutations escape suppression by cellular miRNAs (20–22). These findings suggest that since inhibition of viral replication and packaging of miRNAs occurs in host cells, certain miRNAs in host cells are assisting viral processing. The preliminary results of the present study suggest that when EV71 infected SH-SY5Y cells, the expression levels of endogenous, cellular let-7b were significantly increased. In addition, a number of studies have demonstrated that let-7b initiates cell cycle arrest and inhibits cell proliferation by targeting the expression of cell cycle-related proteins (23–26). Thus, as determined by these data, EV71 is hypothesized to inhibit host cell growth and promote apoptosis through stimulation of host let-7b expression.

In the present study, the SH-SY5Y cell line served as model host cells to determine injury following EV71 infection. EV71 infection was observed to undermine mitochondrial stability in these cells. Simultaneously, EV71 arrested cell cycle progression and subsequently inhibited the proliferation of host cells. EV71 stimulated the overexpression of apoptosis-related genes and induced host cell apoptosis. Conversely, through analysis of epigenetic regulation of EV71 in host cells, EV71 infection was found to stimulate endogenous miRNA let-7b expression; let-7b suppressed the expression of the target gene CCND1 and induced normal cell cycle arrest in host cells. To further confirm that EV71 induced cell cycle arrest through let-7b, 2′-O-Methyl-RNA oligonucleotides were used to inhibit endogenous let-7b expression levels. The assay results revealed that following EV71 exposure, cell cycle arrest in the 2′-O-Methyl-RNA transfected group cell was significantly reduced compared with that in the mock-transfected cells. In conclusion, the present study demonstrates that EV71 inhibits growth and proliferation of host cells through stimulating the expression of miRNA let-7b. Furthermore, the findings suggest that miRNA let-7b is a potential candidate for antiviral therapy in HFMD.

Acknowledgments

The present study was supported by the National Natural Science Foundation of China (grant nos. 81202811, 31100139, 31140037), the Shanghai Municipal Health Bureau Fund (grant nos. 20124320), the National Natural Science Foundation of China (grant no. 31140037) and the China Postdoctoral Science Foundation (no. 2014M550250).

Abbreviations:

HFMD

hand, foot and mouth disease

CVA16

Coxsackie virus A16

miRNA

microRNA

HMGA

H-RAS and high-mobility group AT-hook

References

1 

Cui L, Guo X, Qi Y, et al: Identification of miRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol. 2010:4259392010. View Article : Google Scholar

2 

Cui L, Qi Y, Li H, et al: Serum miRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One. 6:e270712011. View Article : Google Scholar

3 

Hu W, Wang X, Ding X, et al: MiRNA-141 represses HBV replication by targeting PPARA. PLoS One. 7:e341652012. View Article : Google Scholar

4 

Houzet L, Klase Z, Yeung ML, et al: The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1. Nucleic Acids Res. 40:11684–11696. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Narbus CM, Israelow B, Sourisseau M, et al: HepG2 cells expressing miRNA miR-122 support the entire hepatitis C virus life cycle. J Virol. 85:12087–12092. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Umbach JL and Cullen BR: In-depth analysis of Kaposi’s sarcoma-associated herpesvirus miRNA expression provides insights into the mammalian miRNA-processing machinery. J Virol. 84:695–703. 2009. View Article : Google Scholar

7 

Sumazin P, Yang X, Chiu HS, et al: An extensive miRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell. 147:370–381. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Poulton JS, Huang YC, Smith L, et al: The miRNA pathway regulates the temporal pattern of Notch signaling in Drosophila follicle cells. Development. 138:1737–1745. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Lei P, Li Y, Chen X, Yang S and Zhang J: Microarray based analysis of miRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res. 1284:191–201. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Bartel DP: MiRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Yoo AS, Sun AX, Li L, et al: MiRNA-mediated conversion of human fibroblasts to neurons. Nature. 476:228–231. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Dai Y, Diao Z, Sun H, et al: MiRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides. Hum Reprod. 26:1882–1891. 2011. View Article : Google Scholar : PubMed/NCBI

13 

He L and Hannon GJ: MiRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI

14 

El Ouaamari A, Baroukh N, Martens GA, et al: miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes. 57:2708–2717. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Liu T, Shen D, Xing S, et al: Attenuation of exogenous angiotensin II stress-induced damage and apoptosis in human vascular endothelial cells via miRNA-155 expression. Int J Mol Med. 31:188–196. 2013.

16 

Liu T, Cheng W, Huang Y, et al: Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous miRNA-145 and increased Sox2 expression. Exp Cell Res. 318:424–434. 2011. View Article : Google Scholar

17 

Liu T, Huang Y, Liu J, et al: MiRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression. Stem Cells Dev. 22:1839–1850. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Cheng W, Liu T, Wan X, Gao Y and Wang H: MiRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J. 279:2047–2059. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Qin W, Ren Q, Liu T, Huang Y and Wang J: MiRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett. 587:1434–1439. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Wen BP, Dai HJ, Yang YH, Zhuang Y and Sheng R: MiRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 56:195–200. 2013. View Article : Google Scholar

21 

Zheng Z, Ke X, Wang M, et al: Human miRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol. 87:5645–5656. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Li Y, Xie J, Xu X, et al: MiRNA-548 down-regulates host antiviral response via direct targeting of IFN-lambda1. Protein Cell. 4:130–141. 2013. View Article : Google Scholar

23 

Barh D, Malhotra R, Ravi B and Sindhurani P: MiRNA let-7: an emerging next-generation cancer therapeutic. Curr Oncol. 17:70–80. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Schultz J, Lorenz P, Gross G, Ibrahim S and Kunz M: MiRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 18:549–557. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Dangi-Garimella S, Yun J, Eves EM, et al: Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 28:347–358. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Yu F, Yao H, Zhu P, et al: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Chen TC, Lai YK, Yu CK and Juang JL: Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol. 9:2676–2688. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Feng Z, Sun X, Wang G, Liu H and Zhu J: LBD29 regulates the cell cycle progression in response to auxin during lateral root formation in Arabidopsis thaliana. Ann Bot. 110:1–10. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Wang Z, Tang X, Li Y, et al: 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. Eur J Pharmacol. 588:9–17. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Du X, Wang H, Xu F, Huang Y, Liu Z and Liu T: Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol Med Rep 12: 953-959, 2015.
APA
Du, X., Wang, H., Xu, F., Huang, Y., Liu, Z., & Liu, T. (2015). Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Molecular Medicine Reports, 12, 953-959. https://doi.org/10.3892/mmr.2015.3482
MLA
Du, X., Wang, H., Xu, F., Huang, Y., Liu, Z., Liu, T."Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression". Molecular Medicine Reports 12.1 (2015): 953-959.
Chicago
Du, X., Wang, H., Xu, F., Huang, Y., Liu, Z., Liu, T."Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression". Molecular Medicine Reports 12, no. 1 (2015): 953-959. https://doi.org/10.3892/mmr.2015.3482
Copy and paste a formatted citation
x
Spandidos Publications style
Du X, Wang H, Xu F, Huang Y, Liu Z and Liu T: Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol Med Rep 12: 953-959, 2015.
APA
Du, X., Wang, H., Xu, F., Huang, Y., Liu, Z., & Liu, T. (2015). Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Molecular Medicine Reports, 12, 953-959. https://doi.org/10.3892/mmr.2015.3482
MLA
Du, X., Wang, H., Xu, F., Huang, Y., Liu, Z., Liu, T."Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression". Molecular Medicine Reports 12.1 (2015): 953-959.
Chicago
Du, X., Wang, H., Xu, F., Huang, Y., Liu, Z., Liu, T."Enterovirus 71 induces apoptosis of SH‑SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression". Molecular Medicine Reports 12, no. 1 (2015): 953-959. https://doi.org/10.3892/mmr.2015.3482
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team